Transplantable bioartificial pancreas devices: Current status and future prospects

Langenbeck's Archives of Surgery

Volumn 400, Issue 5, 2015, Pages 531-540

  Ludwig, Barbara ^a,b,c   Ludwig, Stefan ^d  

^a CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Diabetes; Encapsulation; Transplantation

Indexed keywords

ALGINIC ACID; INSULIN;

ALLOGRAFT; BIOARTIFICIAL ORGAN; BIOCOMPATIBILITY; DIABETES MELLITUS; HUMAN; IMMUNITY; INFLAMMATION; INSULIN RELEASE; MATERIAL COATING; MICROCAPSULE; NANOENCAPSULATION; NONHUMAN; OXYGENATION; PANCREAS; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; TRANSPLANTABLE BIOARTIFICIAL PANCREAS DEVICES; XENOGRAFT; ANIMAL; ARTIFICIAL ORGAN; DIABETES MELLITUS, TYPE 1; GRAFT SURVIVAL; PATIENT SELECTION;

ANIMALS; ARTIFICIAL ORGANS; DIABETES MELLITUS, TYPE 1; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; PATIENT SELECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84943450414     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-015-1314-y     Document Type: Review

References (98)

1. Gruessner RW, Gruessner AC (2014)What defines success in pancreas and islet transplantation-insulin independence or prevention of hypoglycemia? A review. Transplant Proc 46(6):1898–1899
2. Maffi P, Secchi A (2015).Clinical results of islet transplantation. Pharmacol Res
3. Balamurugan AN, Naziruddin B, Lockridge A, Tiwari M, Loganathan G, Takita M, Matsumoto S, Papas K, Trieger M, Rainis H, Kin T, Kay TW, Wease S, Messinger S, Ricordi C, Alejandro R, Markmann J, Kerr-Conti J, Rickels MR, Liu C, Zhang X, Witkowski P, Posselt A, Maffi P, Secchi A, Berney T, O’Connell PJ, Hering BJ, Barton FB (2014) Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999–2010. Am J Transplant 14(11):2595–2606
4. Robertson RP (2015) Islet transplantation for type 1 diabetes, 2015: what have we learned from alloislet and autoislet successes? Diabetes Care 38(6):1030–1035
5. Matsumoto S, Takita M, Chaussabel D, Noguchi H, Shimoda M, Sugimoto K, Itoh T, Chujo D, SoRelle J, Onaca N, Naziruddin B, Levy MF (2011) Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1β and TNF-α. Cell Transplant 20(10):1641–1647
6. Fridell JA, Rogers J, Stratta RJ (2010) The pancreas allograft donor: current status, controversies, and challenges for the future. Clin Transpl 24(4):433–449
7. Stegall MD, Dean PG, Sung R, Guidinger MK, McBride MA, Sommers C, Basadonna G, Stock PG, Leichtman AB (2007) The rationale for the new deceased donor pancreas allocation schema. Transplantation 83(9):1156–1161
8. Nilsson B, Ekdahl KN, Korsgren O (2011) Control of instant bloodmediated inflammatory reaction to improve islets of Langerhans engraftment. Curr Opin Organ Transplant 16(6):620–626
9. Krishnan R, Alexander M, Robles L, Foster CE 3rd, Lakey JR (2014) Islet and stem cell encapsulation for clinical transplantation. Rev Diabet Stud 11(1):84–101
10. Scharp DW, Mason NS, Sparks RE (1984) Islet immuno-isolation: the use of hybrid artificial organs to prevent islet tissue rejection. World J Surg 8(2):221–229
11. Algire GH, Weaver JM, Prehn RT (1954) Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immunized mice. J Natl Cancer Inst 15(3):493–507
12. Weaver JM, Algire GH, Prehn RT (1955) The growth of cells in vivo in diffusion chambers. II. The role of cells in the destruction of homografts in mice. J Natl Cancer Inst 15(6):1737–1767
13. Algire GH, Weaver JM, Prehn RT (1957) Studies on tissue homotransplantation in mice, using diffusion-chamber methods. Ann N YAcad Sci 64(5):1009–1013
14. Algire GH, Borders ML, Evans VJ (1958) Studies of heterografts in diffusion chambers in mice. J Natl Cancer Inst 20(6):1187–1201
15. Algire GH (1957) Summary of studies of transplantation of homologous tissues. Fed Proc 16(2):601–602
16. Algire GH (1957) Diffusion-chamber techniques for studies of cellular immunity. Ann N YAcad Sci 69(4):663–667
17. Monaco AP, Maki T, Ozato H, Carretta M, Sullivan SJ, Borland KM, Mahoney MD, Chick WL, Muller TE, Wolfrum J et al (1991) Transplantation of islet allografts and xenografts in totally pancreatectomized diabetic dogs using the hybrid artificial pancreas. Ann Surg 214(3):339–360, discussion 361-332
18. Hymer WC, Wilbur DL, Page R, Hibbard E, Kelsey RC, Hatfield JM (1981) Pituitary hollow fiber units in vivo and in vitro. Neuroendocrinology 32(6):339–349
19. Zekorn T, Siebers U, Filip L, Mauer K, Schmitt U, Bretzel RG, Federlin K (1989) Bioartificial pancreas: the use of different hollow fibers as a diffusion chamber. Transplant Proc 21(1 Pt 3): 2748–2750
20. Maki T, Ubhi CS, Sanchez-Farpon H, Sullivan SJ, Borland K, Muller TE, Solomon BA, Chick WL, Monaco AP (1991) Successful treatment of diabetes with the biohybrid artificial pancreas in dogs. Transplantation 51(1):43–51
21. Maki T, Mullon CJ, Solomon BA, Monaco AP (1995) Novel delivery of pancreatic islet cells to treat insulin-dependent diabetes mellitus. Clin Pharmacokinet 28(6):471–482
22. Rafael E, Wernerson A, Arner P, Wu GS, Tibell A (1999) In vivo evaluation of glucose permeability of an immunoisolation device intended for islet transplantation: a novel application of the microdialysis technique. Cell Transplant 8(3):317–326
23. Rafael E, Wernerson A, Arner P, Tibell A (1999) In vivo studies on insulin permeability of an immunoisolation device intended for islet transplantation using the microdialysis technique. Eur Surg Res 31(3):249–258
24. Scharp DW, Marchetti P (2014) Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution. Adv Drug Deliv Rev 67–68:35–73
25. de Groot M, Schuurs TA, van Schilfgaarde R (2004) Causes of limited survival of microencapsulated pancreatic islet grafts. J Surg Res 121(1):141–150
26. Barkai U, Weir GC, Colton CK, Ludwig B, Bornstein SR, Brendel MD, Neufeld T, Bremer C, Leon A, Evron Y, Yavriyants K, Azarov D, Zimermann B, Maimon S, Shabtay N, Balyura M, Rozenshtein T, Vardi P, Bloch K, de Vos P, Rotem A (2013) Enhanced oxygen supply improves islet viability in a new bioartificial pancreas. Cell Transplant 22(8):1463–1476
27. Ludwig B, Zimerman B, Steffen A, Yavriants K, Azarov D, Reichel A, Vardi P, German T, Shabtay N, Rotem A, Evron Y, Neufeld T, Mimon S, Ludwig S, Brendel MD, Bornstein SR, Barkai U (2010) A novel device for islet transplantation providing immune protection and oxygen supply. Horm Metab Res 42(13):918–922
28. Neufeld T, Ludwig B, Barkai U, Weir GC, Colton CK, Evron Y, Balyura M, Yavriyants K, Zimermann B, Azarov D, Maimon S, Shabtay N, Rozenshtein T, Lorber D, Steffen A, Willenz U, Bloch K, Vardi P, Taube R, de Vos P, Lewis EC, Bornstein SR, Rotem A (2013) The efficacy of an immunoisolating membrane system for islet xenotransplantation in minipigs. PLoS One 8(8):e70150
29. Ludwig B, Rotem A, Schmid J, Weir GC, Colton CK, Brendel MD, Neufeld T, Block NL, Yavriyants K, Steffen A, Ludwig S, Chavakis T, Reichel A, Azarov D, Zimermann B, Maimon S, Balyura M, Rozenshtein T, Shabtay N, Vardi P, Bloch K, de Vos P, Schally AV, Bornstein SR, Barkai U (2012) Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc Natl Acad Sci U S A 109(13):5022–5027
30. Ludwig B, Reichel A, Steffen A, Zimerman B, Schally AV, Block NL, Colton CK, Ludwig S, Kersting S, Bonifacio E, Solimena M, Gendler Z, Rotem A, Barkai U, Bornstein SR (2013) Transplantation of human islets without immunosuppression. Proc Natl Acad Sci U S A 110(47):19054–19058
31. Lanza RP, Beyer AM, Staruk JE, Chick WL (1993) Biohybrid artificial pancreas. Long-term function of discordant islet xenografts in streptozotocin diabetic rats. Transplantation 56(5):1067–1072
32. Lanza RP, Borland KM, Lodge P, Carretta M, Sullivan SJ, Muller TE, Solomon BA, Maki T, Monaco AP, Chick WL (1992) Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 41(7):886–889
33. Lanza RP, Borland KM, Staruk JE, Appel MC, Solomon BA, Chick WL (1992) Transplantation of encapsulated canine islets into spontaneously diabetic BB/Wor rats without immunosuppression. Endocrinology 131(2):637–642
34. Merani S, Toso C, Emamaullee J, Shapiro AM (2008) Optimal implantation site for pancreatic islet transplantation. Br J Surg 95(12):1449–1461
35. de Vos P, Spasojevic M, Faas MM (2010) Treatment of diabetes with encapsulated islets. Adv Exp Med Biol 670:38–53
36. Teramura Y, Iwata H (2010) Bioartificial pancreas microencapsulation and conformal coating of islet of Langerhans. Adv Drug Deliv Rev 62(7–8):827–840
37. Soon-Shiong P, Feldman E, Nelson R, Komtebedde J, Smidsrod O, Skjak-Braek G, Espevik T, Heintz R, Lee M (1992) Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 54(5):769–774
38. Lanza RP, Ecker DM, Kuhtreiber WM, Marsh JP, Ringeling J, Chick WL (1999) Transplantation of islets using microencapsulation: studies in diabetic rodents and dogs. J Mol Med (Berl) 77(1): 206–210
39. Dufrane D, Gianello P (2012) Macro- or microencapsulation of pig islets to cure type 1 diabetes. World J Gastroenterol 18(47): 6885–6893
40. Calafiore R (1992) Transplantation of microencapsulated pancreatic human islets for therapy of diabetes mellitus. A preliminary report. Asaio J 38(1):34–37
41. Paredes Juarez GA, Spasojevic M, Faas MM, de Vos P (2014) Immunological and technical considerations in application of alginate-based microencapsulation systems. Front Bioeng Biotechnol 2:26
42. Opara EC, McQuilling JP, Farney AC (2013) Microencapsulation of pancreatic islets for use in a bioartificial pancreas. Methods Mol Biol 1001:261–266
43. Calafiore R, Basta G (2014) Clinical application of microencapsulated islets: actual prospectives on progress and challenges. Adv Drug Deliv Rev 67–68:84–92
44. De Vos P, Van Straaten JF, Nieuwenhuizen AG, de Groot M, Ploeg RJ, De Haan BJ, Van Schilfgaarde R (1999) Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes 48(7):1381–1388
45. Matsumoto S, Tan P, Baker J, Durbin K, Tomiya M, Azuma K, Doi M, Elliott RB (2014) Clinical porcine islet xenotransplantation under comprehensive regulation. Transplant Proc 46(6):1992–1995
46. Matsuda T, Kitamura T, Iwata H, Takano H, Akutsu T (1988) A hybrid artificial vascular graft based upon an organ reconstruction model. Significance and design criteria of an artificial basement membrane. ASAIO Trans 34(3):640–643
47. Wang T, Lacik I, Brissova M, Anilkumar AV, Prokop A, Hunkeler D, Green R, Shahrokhi K, Powers AC (1997) An encapsulation system for the immunoisolation of pancreatic islets. Nat Biotechnol 15(4):358–362
48. Wang T, Adcock J, Kuhtreiber W, Qiang D, Salleng KJ, Trenary I, Williams P (2008) Successful allotransplantation of encapsulated islets in pancreatectomized canines for diabetic management without the use of immunosuppression. Transplantation 85(3):331–337
49. Drumheller PD, Elbert DL, Hubbell JA (1994) Multifunctional poly(ethylene glycol) semi-interpenetrating polymer networks as highly selective adhesive substrates for bioadhesive peptide grafting. Biotechnol Bioeng 43(8):772–780
50. Sawhney AS, Pathak CP, Hubbell JA (1993) Interfacial photopolymerization of poly(ethylene glycol)-based hydrogels upon alginate-poly(l-lysine) microcapsules for enhanced biocompatibility. Biomaterials 14(13):1008–1016
51. Sawhney AS, Pathak CP, Hubbell JA (1994) Modification of islet of langerhans surfaces with immunoprotective poly(ethylene glycol) coatings via interfacial photopolymerization. Biotechnol Bioeng 44(3):383–386
52. Hill RS, Cruise GM, Hager SR, Lamberti FV, Yu X, Garufis CL, Yu Y, Mundwiler KE, Cole JF, Hubbell JA, Hegre OD, Scharp DW (1997) Immunoisolation of adult porcine islets for the treatment of diabetes mellitus. The use of photopolymerizable polyethylene glycol in the conformal coating of mass-isolated porcine islets. Ann N YAcad Sci 831:332–343
53. Cruise GM, Hegre OD, Lamberti FV, Hager SR, Hill R, Scharp DS, Hubbell JA (1999) In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant 8(3):293–306
54. Tomei AA, Manzoli V, Fraker CA, Giraldo J, Velluto D, Najjar M, Pileggi A (2014) Device design and materials optimization of conformal coating for islets of Langerhans. Proc Natl Acad Sci U S A 111(29):10514–10519
55. Wilson JT, Cui W, Chaikof EL (2008) Layer-by-layer assembly of a conformal nanothin PEG coating for intraportal islet transplantation. Nano Lett 8(7):1940–1948
56. Gattas-Asfura KM, Stabler CL (2013) Bioorthogonal layer-bylayer encapsulation of pancreatic islets via hyperbranched polymers. ACS Appl Mater Interfaces 5(20):9964–9974
57. Teramura Y, Kaneda Y, Iwata H (2007) Islet-encapsulation in ultrathin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials 28(32):4818–4825
58. Rengifo HR, Giraldo JA, Labrada I, Stabler CL (2014) Long-term survival of allograft murine islets coated via covalently stabilized polymers. Adv Healthcare Mater 3(7):1061–1070
59. Zhi ZL, Kerby A, King AJ, Jones PM, Pickup JC (2012) Nanoscale encapsulation enhances allograft survival and function of islets transplanted in a mouse model of diabetes. Diabetologia 55(4): 1081–1090
60. Ludwig B, Ludwig S, Steffen A, Saeger HD, Bornstein SR (2010) Islet versus pancreas transplantation in type 1 diabetes: competitive or complementary? Curr Diab Rep 10(6):506–511
61. van der Windt DJ, Echeverri GJ, Ijzermans JN, Cooper DK (2008) The choice of anatomical site for islet transplantation. Cell Transplant 17(9):1005–1014
62. van der Windt DJ, Bottino R, Casu A, Campanile N, Cooper DK (2007) Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation 14(4):288–297
63. Robson SC, Cooper DK, d’Apice AJ (2000) Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 7(3):166–176
64. Kim JH, Oh BJ, Lee HN, Park HS, Park SG, Park KS (2011) Endothelial colony-forming cell coating of pig islets prevents xenogeneic instant blood-mediated inflammatory reaction. Cell Transplant 20(11-12):1805–1815
65. Hwang JW, Jung HS, Lee DY(2011) Inhibition of platelet adhesion onto intrahepatically transplanted islets using PEGylation for attenuating instant blood-mediated inflammatory reaction (IBMIR). J Control Release 152(Suppl 1):e213–e214
66. Teramura Y, Iwata H (2011) Improvement of graft survival by surface modification with poly(ethylene glycol)-lipid and urokinase in intraportal islet transplantation. Transplantation 91(3):271–278
67. Luan NM, Teramura Y, Iwata H (2011) Immobilization of soluble complement receptor 1 on islets. Biomaterials 32(20):4539–4545
68. Luan NM, Teramura Y, Iwata H (2011) Layer-by-layer coimmobilization of soluble complement receptor 1 and heparin on islets. Biomaterials 32(27):6487–6492
69. Chen H, Teramura Y, Iwata H (2011) Co-immobilization of urokinase and thrombomodulin on islet surfaces by poly(ethylene glycol)- conjugated phospholipid. J Control Release 150(2):229–234
70. Teramura Y, Iwata H (2009) Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation. Transplantation 88(5):624–630
71. Im BH, Jeong JH, Haque MR, Lee DY, Ahn CH, Kim JE, Byun Y (2013) The effects of 8-arm-PEG-catechol/heparin shielding system and immunosuppressive drug, FK506 on the survival of intraportally allotransplanted islets. Biomaterials 34(8):2098–2106
72. Hilbrands R, Huurman VA, Gillard P, Velthuis JH, De Waele M, Mathieu C, Kaufman L, Pipeleers-Marichal M, Ling Z, Movahedi B, Jacobs-Tulleneers-Thevissen D, Monbaliu D, Ysebaert D, Gorus FK, Roep BO, Pipeleers DG, Keymeulen B (2009) Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes 58(10):2267–2276
73. Harlan DM, Kenyon NS, Korsgren O, Roep BO (2009) Current advances and travails in islet transplantation. Diabetes 58(10): 2175–2184
74. Calafiore R, Basta G, Luca G, Lemmi A, Racanicchi L, Mancuso F, Montanucci MP, Brunetti P (2006) Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. Transplant Proc 38(4):1156–1157
75. O’Sullivan ES, Vegas A, Anderson DG, Weir GC (2011) Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. Endocr Rev 32(6):827–844
76. Pierson RN 3rd (2009) Antibody-mediated xenograft injury: mechanisms and protective strategies. Transpl Immunol 21(2):65–69
77. Kirchhof N, Shibata S, Wijkstrom M, Kulick DM, Salerno CT, Clemmings SM, Heremans Y, Galili U, Sutherland DE, Dalmasso AP, Hering BJ (2004) Reversal of diabetes in nonimmunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 11(5):396–407
78. Soderlund J, Wennberg L, Castanos-Velez E, Biberfeld P, Zhu S, Tibell A, Groth CG, Korsgren O (1999) Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study. Transplantation 67(6):784–791
79. de Vos P, Marchetti P (2002) Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets. TrendsMol Med 8(8):363–366
80. Klymiuk N, van Buerck L, Bahr A, Offers M, Kessler B, Wuensch A, Kurome M, Thormann M, Lochner K, Nagashima H, Herbach N, Wanke R, Seissler J, Wolf E (2012) Xenografted islet cell clusters from INSLEA29Y transgenic pigs rescue diabetes and prevent immune rejection in humanized mice. Diabetes 61(6):1527–1532
81. Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49(11):1751–1760
82. Hellman B, Gylfe E, Bergsten P, Grapengiesser E, Lund PE, Berts A, Tengholm A, Pipeleers DG, Ling Z (1994) Glucose induces oscillatory Ca2+ signalling and insulin release in human pancreatic beta cells. Diabetologia 37(Suppl 2):S11–S20
83. Marchetti P, Scharp DW, McLear M, Gingerich R, Finke E, Olack B, Swanson C, Giannarelli R, Navalesi R, Lacy PE (1994) Pulsatile insulin secretion from isolated human pancreatic islets. Diabetes 43(6):827–830
84. Buchwald P, Cechin SR, Weaver JD, Stabler CL (2015) Experimental evaluation and computationalmodeling of the effects of encapsulation on the time-profile of glucose-stimulated insulin release of pancreatic islets. Biomed Eng Online 14(1):28
85. Blasi P, Luca G, Mancuso F, Schoubben A, Calvitti M, Giovagnoli S, Basta G, Becchetti E, Ricci M, Calafiore R (2013) Conformal polymer coatings for pancreatic islets transplantation. Int J Pharm 440(2):141–147
86. Orive G, Hernandez RM, Gascon AR, Calafiore R, Chang TM, De Vos P, Hortelano G, Hunkeler D, Lacik I, Shapiro AM, Pedraz JL (2003) Cell encapsulation: promise and progress. Nat Med 9(1):104–107
87. Orive G, Gascon AR, Hernandez RM, Igartua M, Luis Pedraz J (2003) Cell microencapsulation technology for biomedical purposes: novel insights and challenges. Trends Pharmacol Sci 24(5):207–210
88. de Vos P, Hamel AF, Tatarkiewicz K (2002) Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 45(2):159–173
89. Vaithilingam V, Kollarikova G, Qi M, Lacik I, Oberholzer J, Guillemin GJ, Tuch BE (2011) Effect of prolonged gelling time on the intrinsic properties of barium alginate microcapsules and its biocompatibility. J Microencapsul 28(6):499–507
90. De Vos P, Vegter D, De Haan BJ, Strubbe JH, Bruggink JE, Van Schilfgaarde R (1996) Kinetics of intraperitoneally infused insulin in rats. Functional implications for the bioartificial pancreas. Diabetes 45(8):1102–1107
91. Yang HK, Yoon KH (2015) Current status of encapsulated islet transplantation. J Diabet Complications
92. Pareta R, McQuilling JP, Sittadjody S, Jenkins R, Bowden S, Orlando G, Farney AC, Brey EM, Opara EC (2014) Long-term function of islets encapsulated in a redesigned alginate microcapsule construct in omentum pouches of immune-competent diabetic rats. Pancreas 43(4):605–613
93. Juang JH, Bonner-Weir S, Ogawa Y, Vacanti JP, Weir GC (1996) Outcome of subcutaneous islet transplantation improved by polymer device. Transplantation 61(11):1557–1561
94. De Vos P, Hillebrands JL, De Haan BJ, Strubbe JH, Van Schilfgaarde R (1997) Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets. Transplantation 63(6):824–830
95. Eberhard D, Kragl M, Lammert E (2010) ‘Giving and taking’: endothelial and beta-cells in the islets of Langerhans. Trends Endocrinol Metab 21(8):457–463
96. Lammert E, Cleaver O, Melton D (2001) Induction of pancreatic differentiation by signals fromblood vessels. Science 294(5542):564–567
97. Denner J, Graham M (2015) Xenotransplantation of islet cells: what can the non-human primate model bring for the evaluation of efficacy and safety? Xenotransplantation
98. Graham ML, Bellin MD, Papas KK, Hering BJ, Schuurman HJ (2011) Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation. Xenotransplantation 18(6):328–342